UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000045349
Receipt number R000051102
Scientific Title Trial of the intraoral peptidase activity of patients with periodontal disease
Date of disclosure of the study information 2021/10/01
Last modified on 2024/03/04 09:05:53

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of the intraoral enzyme activity of patients with periodontal disease

Acronym

Clinical study of patients with periodontal disease

Scientific Title

Trial of the intraoral peptidase activity of patients with periodontal disease

Scientific Title:Acronym

Trial of intraoral peptidase activity

Region

Japan


Condition

Condition

periodontal disease

Classification by specialty

Dental medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This study aimed to clarify the relevance between the severity of periodontal disease and the bacterial peptidase activity.

Basic objectives2

Others

Basic objectives -Others

Bacterial flora analysis of patients with periodontal disease

Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Peptidase activity and bacterial flora analysis

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Other

Interventions/Control_1

Sampling (saliva, GCF), once

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. The patient who consulted Oral Management Center of Nagasaki University Hospital
2. The patient 20 years or older at the time of the agreement acquisition
3. The patient who received an examination of periodontal tissue

Key exclusion criteria

1. The patient who has difficulty in saliva collection for dry mouth.
2. The patient with the past of antimicrobial and/or the anti-inflammatory dosage for three months before sampling.
3. The patient with the past of the dosage in the periodontal pocket of the antimicrobial.
4. The patient during human DPP4 inhibitor remedy.
5. The previously treated patient with radiation therapy or chemotherapy because of a malignant tumor.
6. The patient who was judged not to participate in this study by us.

Target sample size

60


Research contact person

Name of lead principal investigator

1st name Haruka
Middle name
Last name Nishimata

Organization

Nagasaki University Hospital

Division name

Pediatric Dentistry

Zip code

852-8588

Address

1-7-1 Sakamoto, Nagasaki City

TEL

095-819-7674

Email

nishimata@nagasaki-u.ac.jp


Public contact

Name of contact person

1st name Haruka
Middle name
Last name Nishimata

Organization

Nagasaki University Graduate School of Biomedical Sciences

Division name

Pediatric Dentistry

Zip code

852-8588

Address

1-7-1 Sakamoto, Nagasaki City

TEL

095-819-7674

Homepage URL


Email

nishimata@nagasaki-u.ac.jp


Sponsor or person

Institute

Nagasaki University

Institute

Department

Personal name



Funding Source

Organization

Japan Society for the Promotion of Science

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Nagasaki University Hospital Clinical Research Ethics Committee

Address

1-7-1 Sakamoto, Nagasaki-shi

Tel

095-819-7229

Email

gaibushikin@ml.nagasaki-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

長崎大学病院(長崎県)


Other administrative information

Date of disclosure of the study information

2021 Year 10 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2021 Year 08 Month 18 Day

Date of IRB

2021 Year 08 Month 24 Day

Anticipated trial start date

2022 Year 08 Month 12 Day

Last follow-up date

2024 Year 12 Month 31 Day

Date of closure to data entry

2025 Year 12 Month 31 Day

Date trial data considered complete

2025 Year 12 Month 31 Day

Date analysis concluded

2025 Year 12 Month 31 Day


Other

Other related information

none


Management information

Registered date

2021 Year 09 Month 02 Day

Last modified on

2024 Year 03 Month 04 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000051102